According to Lantern Pharma's latest financial reports the company has $38.35 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $55.19 M | -21.96% |
2021-12-31 | $70.72 M | 267.8% |
2020-12-31 | $19.22 M | 1460.78% |
2019-12-31 | $1.23 M | 176.76% |
2018-12-31 | $0.44 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | $0.31 B | 725.85% | ๐บ๐ธ USA |